Innovation1 Biotech Inc.
IVBT · OTC
8/31/2023 | 8/31/2022 | 8/31/2021 | 8/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $3 | $1 |
| % Growth | – | -100% | 160.8% | – |
| Cost of Goods Sold | $53 | $2,546 | $1 | $3 |
| Gross Profit | -$53 | -$2,546 | $2 | -$2 |
| % Margin | – | – | 53.9% | -151% |
| R&D Expenses | $15 | $201 | $0 | $0 |
| G&A Expenses | $685 | $2,497 | $240 | $212 |
| SG&A Expenses | $1,200 | $2,502 | $241 | $215 |
| Sales & Mktg Exp. | $10 | $5 | $1 | $3 |
| Other Operating Expenses | $0 | -$0 | $0 | $0 |
| Operating Expenses | $1,215 | $2,703 | $241 | $215 |
| Operating Income | -$1,367 | -$5,250 | -$258 | -$217 |
| % Margin | – | – | -8,390.9% | -18,374.3% |
| Other Income/Exp. Net | -$4,621 | -$35,628 | $1,298 | -$2,363 |
| Pre-Tax Income | -$5,988 | -$40,878 | $1,040 | -$2,580 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$5,988 | -$40,878 | $1,040 | -$2,580 |
| % Margin | – | – | 33,766.2% | -218,458.9% |
| EPS | -0.7 | -2.73 | 5.53 | -8.59 |
| % Growth | 74.4% | -149.4% | 164.4% | – |
| EPS Diluted | -0.7 | -2.73 | 5.53 | -8.59 |
| Weighted Avg Shares Out | 20,184 | 15,226 | 188 | 294 |
| Weighted Avg Shares Out Dil | 20,184 | 15,226 | 188 | 300 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $14 | $56 | $41 |
| Interest Expense | $252 | $6 | $220 | $1,297 |
| Depreciation & Amortization | $53 | $2,546 | $1 | $3 |
| EBITDA | -$5,684 | -$38,326 | $1,261 | -$1,280 |
| % Margin | – | – | 40,941.6% | -108,382.7% |